Correlation Between Tyra Biosciences and RAPT Therapeutics

Can any of the company-specific risk be diversified away by investing in both Tyra Biosciences and RAPT Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tyra Biosciences and RAPT Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tyra Biosciences and RAPT Therapeutics, you can compare the effects of market volatilities on Tyra Biosciences and RAPT Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tyra Biosciences with a short position of RAPT Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tyra Biosciences and RAPT Therapeutics.

Diversification Opportunities for Tyra Biosciences and RAPT Therapeutics

0.14

Correlation Coefficient

Tyra Biosciences  RAPT Therapeutics

Average diversification

The 3 months correlation between Tyra and RAPT is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Tyra Biosciences and RAPT Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RAPT Therapeutics and Tyra Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tyra Biosciences are associated (or correlated) with RAPT Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RAPT Therapeutics has no effect on the direction of Tyra Biosciences i.e., Tyra Biosciences and RAPT Therapeutics go up and down completely randomly.

Pair Corralation between Tyra Biosciences and RAPT Therapeutics

Given the investment horizon of 90 days Tyra Biosciences is expected to under-perform the RAPT Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Tyra Biosciences is 1.66 times less risky than RAPT Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The RAPT Therapeutics is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  202.00  in RAPT Therapeutics on August 31, 2024 and sell it today you would lose (76.00) from holding RAPT Therapeutics or give up 37.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tyra Biosciences  vs.  RAPT Therapeutics

Tyra Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tyra Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

RAPT Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RAPT Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Tyra Biosciences and RAPT Therapeutics

The main advantage of trading using opposite Tyra Biosciences and RAPT Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tyra Biosciences position performs unexpectedly, RAPT Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will offset losses from the drop in RAPT Therapeutics' long position.

The idea behind Tyra Biosciences and RAPT Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.